Literature DB >> 564806

Immune-complex mediated colitis in rabbits. An experimental model.

H J Hodgson, B J Potter, J Skinner, D P Jewell.   

Abstract

An experimental colitis in rabbits is described, following the intravenous injection of preformed immune complexes of human serum albumin (HSA) and anti-HSA into non-sensitised rabbits. Tissue damage was localised to the colon by the Auer technique of inducing local non-specific inflammation, by the rectal instillation of dilute formalin. Formalin alone gave transient changes that reverted to normal within 24 hours. In rabbits given intravenous immune complexes formed in antigen-excess, a severe colitis was initiated, with histological features including mucosal ulceration, mixed inflammatory cell infiltration in the lamina propria, and crypt abscess formation. It is possible that immune-complex damage may be one of the pathogenic mechanisms involved in human ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564806      PMCID: PMC1411904          DOI: 10.1136/gut.19.3.225

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  Immune complexes in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

2.  Enterobacterial common antigen-induced lymphocyte reactivity in inflammatory bowel disease.

Authors:  D M Bull; T F Ignaczak
Journal:  Gastroenterology       Date:  1973-01       Impact factor: 22.682

3.  Studies on circulating immune complexes. 3. Factors governing the ability of circulating complexes to localize in blood vessels.

Authors:  C G Cochrane; D Hawkins
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

4.  Evidence for complement-binding immune complexes in adult coeliac disease, Crohn's disease, and ulcerative colitis.

Authors:  W F Doe; C C Booth; D L Brown
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

5.  Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis.

Authors:  E Monteiro; J Fossey; M Shiner; B S Drasar; A C Allison
Journal:  Lancet       Date:  1971-02-06       Impact factor: 79.321

6.  Circulating immune complexes in inflammatory bowel disease.

Authors:  D P Jewell; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1973-06       Impact factor: 4.330

7.  Determination of the sedimentation coefficients of D-glucose-6-phosphate dehydrogenase from normal and deficient human erythrocytes by s-zonal ultracentrifugation.

Authors:  L Funding; J Steensgaard
Journal:  Scand J Clin Lab Invest       Date:  1971-12       Impact factor: 1.713

8.  Immunological studies in ulcerative colitis. 3. Incidence of antibodies to colon-antigen in ulcerative colitis and other gastro-intestinal diseases.

Authors:  R Lagercrantz; S Hammarström; P Perlmann; B E Gustafsson
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

9.  Evidence of an agent transmissible from ulcerative colitis tissue.

Authors:  D R Cave; D N Mitchell; B N Brooke
Journal:  Lancet       Date:  1976-06-19       Impact factor: 79.321

10.  Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets.

Authors:  P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1971-03-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Leukocyte adhesion molecules in animal models of inflammatory bowel disease.

Authors:  Jesús Rivera-Nieves; Gezahegn Gorfu; Klaus Ley
Journal:  Inflamm Bowel Dis       Date:  2008-12       Impact factor: 5.325

2.  Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.

Authors:  S N Murthy; T Anania; H R Clearfield
Journal:  Agents Actions       Date:  1991-09

3.  Immune complex-induced enteropathy. Effects of repeated injections of immune complexes on the small intestine of the rat.

Authors:  L A Hassell; S M Bishara; K J Block
Journal:  Am J Pathol       Date:  1989-01       Impact factor: 4.307

4.  Systemic antibodies towards mucosal bacteria in ulcerative colitis and Crohn's disease differentially activate the innate immune response.

Authors:  E Furrie; S Macfarlane; J H Cummings; G T Macfarlane
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

5.  Deposits of terminal complement complex (TCC) in muscularis mucosae and submucosal vessels in ulcerative colitis and Crohn's disease of the colon.

Authors:  T S Halstensen; T E Mollnes; O Fausa; P Brandtzaeg
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

6.  The characterization of a rabbit model of inflammatory bowel disease.

Authors:  D Anthony; F Savage; V Sams; P Boulos
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

7.  Inhibition of leucocyte motility and prevention of immune-complex experimental colitis by hydroxychloroquine.

Authors:  J M Rhodes; J E McLaughlin; D J Brown; L A Nuttall; D P Jewell
Journal:  Gut       Date:  1982-03       Impact factor: 23.059

8.  Dinitrochlorobenzene-induced colitis in the guinea-pig: studies of colonic lamina propria lymphocytes.

Authors:  M E Glick; Z M Falchuk
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

9.  Chronic immune colitis in rabbits.

Authors:  A S Mee; J E McLaughlin; H J Hodgson; D P Jewell
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

10.  Interleukin 1 suppresses inflammation in rabbit colitis. Mediation by endogenous prostaglandins.

Authors:  F Cominelli; C C Nast; R Llerena; C A Dinarello; R D Zipser
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.